Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1830 clinical trials
A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis (BARRIER)  

Participants will be asked to keep a daily record of their symptoms throughout the study.

Accepts healthy volunteers
  • 0 views
  • 04 Nov, 2025
  • 1 location
TKR Rehabilitation Through the Immersive Virtual Reality in Aquatic Scenarios

Assessments will be performed at baseline and at the end of treatment.

cognitive disorders
edema reduction
drainage
epilepsy
total knee replacement
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors

This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.

cancer
metastatic breast cancer
screening procedures
health screening
hormone therapy
  • 0 views
  • 16 Feb, 2024
  • 5 locations
A Study of ASTX030 (Cedazuridine in Combination With Azacitidine) in MDS CMML or AML

Phase 3 is a randomized open-label crossover study comparing the final oral ASTX030 tablet to SC azacitidine. The duration of the study is expected to be approximately 36 months.

graft versus host disease
raeb
anemia
thrombocytopenia
cedazuridine
  • 0 views
  • 16 Feb, 2024
  • 2 locations
KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

KEAP1/NRF2 mutation status (for eligibility) and STK11/LKB1 status (for stratification) will be determined by next generation sequencing. A commercial liquid biopsy (circulating tumor DNA) NGS test will be provided to study participants free of charge.

liquid biopsy
ros1
systemic therapy
metastasis
NTRK
  • 0 views
  • 16 Feb, 2024
  • 28 locations
NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer

The purpose of this Phase I study is to determine the recommended phase 2 dose (RP2D) and safety profile of NBTXR3 activated by radiation therapy for the treatment of patients with pancreatic cancer that has spread to nearby tissues or lymph nodes (locally advanced) or may be able to be …

adenocarcinoma
metastasis
cancer
pancreatic cancer
endoscopic ultrasound
  • 0 views
  • 16 Feb, 2024
  • 1 location
Analgesic Effect of Oral Glucose in Neonates

However, it has been shown that neurological system known to be associated with pain transmission and modulation, is intact and functional. OBJECTIVE: Our objective is to determine if a 30% glucose solution would reduce pain after circumcision compared with normal saline.

oximetry
circumcision
analgesics
nervousness
  • 0 views
  • 16 Feb, 2024
  • 1 location
CO2 Laser Revision for Burn Related Donor Site Scars

Patients will receive the standard fractional ablative CO2 treatments to their scars resulting from burn wounds allowed to heal by secondary intention and/or those treated with skin grafts. These will be prospectively observed for the duration of the study as well as adjacent normal skin. In addition, a donor site …

scarring
third degree burn
compression therapy
laser therapy
occupational therapies
  • 0 views
  • 05 Aug, 2020
Prevention of Maternal Hypotension During Cesarean Section With Norepinephrine Infusion.

This will be a randomized study aiming at investigating the combination of a norepinephrine infusion and colloid preloading versus the combination of a norepinephrine infusion and crystalloid co-loading for the prevention of maternal hypotension during elective cesarean section

cesarean section
norepinephrine
elective cesarean delivery
crystalloid
maternal hypotension
  • 0 views
  • 16 Feb, 2024
  • 2 locations
An Open-Label Study to Investigate the Safety of Single Ascending Doses in Children and Adolescents With Dravet Syndrome

Stoke Therapeutics is evaluating the safety and tolerability of single ascending doses of STK-001 in patients with Dravet syndrome. Change in seizure frequency and quality of life will be measured as secondary endpoints in this open-label study.

dravet syndrome
scn1a gene
ketogenic diet
tonic
fever
  • 0 views
  • 05 Aug, 2020